Related Experiment Video
Updated: Jun 23, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
Pulmonary Alveolar Microlithiasis: a Case Report in King Hussein Medical Center (KHMC), Amman, Jordan
Rakan M Haddad1, Jafar A Al-Momani1, Abdullah H Al-Omari2
1Department of Internal Medicine, Respiratory Medicine Division, King Hussein Medical Center (KHMC), Amman, Jordan.
Introduction:
Pulmonary Alveolar Microlithiasis (PAM) is a rare disorder that can affect patients at any age, although it is more common to present in the third and fourth decades of life. Most patients are asymptomatic at the time of diagnosis. However, some may present with symptoms of dyspnea or cough. PAM can be sporadic, or it can be hereditary.
Aim:
To focus on the importance of using chest CT scans along with bone scintigraphy to aid in the diagnosis of PAM. The importance of screening all family members is also addressed.
Case Report:
In our case, the patient was a 21-year-old male, coming for routine check-up to be recruited in the army. He was referred to our clinic after the examining doctor noticed that his chest X-Ray was not normal. Upon revising his chest X-ray, he was found to have bilateral fine reticular infiltrates. His physical examination was unremarkable. His spirometry and DLCO were normal. A high-resolution chest CT scan was done, and showed diffuse bilateral microcalcifications with bilateral interstitial and septal thickening. To confirm the diagnosis of PAM, a Technetium-99m methylene diphosphonate (Tc-99m MDP) whole body bone scintigraphy was done, and it showed diffusely increased radiotracer uptake in both lungs. His family members were screened for PAM. His father and sister, who were completely asymptomatic and with normal pulmonary function tests, were found to have PAM as well.
Conclusion:
The use of bone scintigraphy plays an integral role in diagnosing patients with radiological findings consistent with PAM, and it can diagnose PAM without the need for invasive procedures. Once diagnosed, screening of all family members for PAM should be done, even when they are asymptomatic, as more than one-third of the cases have a familial pattern.
Insights
Pulmonary Alveolar Microlithiasis (PAM) diagnosis is aided by chest CT and bone scintigraphy. Family screening is crucial, even for asymptomatic individuals, due to its hereditary nature.
Area of Science:
- Pulmonary medicine
- Radiology
- Genetics
Background:
- Pulmonary Alveolar Microlithiasis (PAM) is a rare, potentially hereditary lung disease.
- Patients are often asymptomatic at diagnosis, presenting later with cough or dyspnea.
- Early detection is challenging due to subtle initial symptoms.
Observation:
- A 21-year-old male presented with abnormal chest X-ray findings.
- High-resolution chest CT revealed diffuse bilateral microcalcifications.
- Technetium-99m methylene diphosphonate (Tc-99m MDP) bone scintigraphy showed increased lung radiotracer uptake.
Findings:
- Chest CT and bone scintigraphy confirmed Pulmonary Alveolar Microlithiasis.
- The patient's asymptomatic father and sister were also diagnosed with PAM.
- A familial pattern was evident, highlighting the hereditary aspect.
Implications:
- Bone scintigraphy is vital for diagnosing PAM, avoiding invasive procedures.
- Screening family members is essential, as over one-third of PAM cases have a familial link.
- Early diagnosis through imaging facilitates timely management and genetic counseling.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Atelectasis II: Pathophysiology
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

